SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$4.21
-6.03%
Mkt Cap $408.14M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+505.7%
Consensus $25.50 vs current $4.21
NASDAQ·Healthcare·Biotechnology
$4.21
-6.03%
Mkt Cap $408.14M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+505.7%
Consensus $25.50 vs current $4.21